| scholarly article | Q13442814 |
| P50 | author | Xixi Liu | Q98772070 |
| Lihua Jiang | Q98772071 | ||
| Qian Liu | Q98772072 | ||
| Jingyun Zhang | Q98772073 | ||
| Wenyan Niu | Q98772074 | ||
| Jianguang Liu | Q98772075 | ||
| Qiumei Zhang | Q98772076 | ||
| P2860 | cites work | Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis | Q24655666 |
| Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass | Q28505908 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Mechanisms of diabetes mellitus-induced bone fragility | Q30241947 | ||
| Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study | Q30980511 | ||
| Association between serum osteocalcin and glucose/lipid metabolism in Chinese Han and Uygur populations with type 2 diabetes mellitus in Xinjiang: two cross-sectional studies | Q33922652 | ||
| Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism | Q34021680 | ||
| Biochemical markers of bone turnover: part I: biochemistry and variability | Q34239361 | ||
| Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway | Q36135658 | ||
| Adiponectin and bone mass density: The InCHIANTI study | Q36215679 | ||
| Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus | Q36431670 | ||
| Glycation endproducts in osteoporosis--is there a pathophysiologic importance? | Q36507705 | ||
| Diabetes-related complications, glycemic control, and falls in older adults | Q36528243 | ||
| Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture | Q36851830 | ||
| The Relationship between Serum Osteocalcin Concentration and Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus – The Role of Osteocalcin in Energy Metabolism. | Q51051136 | ||
| Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity. | Q51270720 | ||
| Significant inverse association between serum osteocalcin and incident type 2 diabetes in a middle-aged cohort. | Q51276751 | ||
| Metabolic syndrome and central fat distribution are related to lower serum osteocalcin concentrations. | Q51343445 | ||
| Effect of age on bone density and bone turnover in men. | Q51591289 | ||
| Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women | Q56100849 | ||
| Calcium metabolism in diabetes mellitus: effect of improved blood glucose control | Q70753730 | ||
| Recent progress in advanced glycation end products and diabetic complications | Q73670071 | ||
| Cross-sectional evaluation of bone metabolism in men | Q74488846 | ||
| Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes | Q83455687 | ||
| Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey | Q83480169 | ||
| Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes | Q83594313 | ||
| Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance | Q83972821 | ||
| Lower bone turnover markers in metabolic syndrome and diabetes: the population-based Study of Health in Pomerania | Q87008482 | ||
| Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes | Q91214142 | ||
| Vitamin D and glycemic control in diabetes mellitus type 2. | Q37127552 | ||
| The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. | Q37705676 | ||
| Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. | Q37823835 | ||
| Bone turnover markers: use in osteoporosis | Q38016073 | ||
| Type 2 diabetes and bone | Q38048186 | ||
| Biochemical bone turnover markers in diabetes mellitus - A systematic review | Q38365736 | ||
| IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. | Q38822669 | ||
| The use of biomarkers in clinical osteoporosis | Q38903116 | ||
| Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease | Q39035413 | ||
| The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs | Q40062475 | ||
| Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone | Q40390871 | ||
| Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. | Q40778071 | ||
| Diabetes mellitus and risk of hip fractures: a meta-analysis | Q41492014 | ||
| Serum levels of bone resorption markers are decreased in patients with type 2 diabetes | Q44094049 | ||
| Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey | Q45058945 | ||
| Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis | Q45138525 | ||
| Bone metabolism in male patients with type 2 diabetes | Q45300536 | ||
| Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk | Q46503292 | ||
| Older women with diabetes have an increased risk of fracture: a prospective study | Q46556380 | ||
| Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study | Q46892036 | ||
| Association of Glycemic Status with Bone Turnover Markers in Type 2 Diabetes Mellitus | Q47149726 | ||
| Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists | Q47881377 | ||
| Role of vitamin D in energy and bone metabolism in postmenopausal women with type 2 diabetes mellitus: A 6-month follow-up evaluation. | Q47929927 | ||
| Association of Bone Mineral Density, Bone Turnover Markers, and Vertebral Fractures with All-Cause Mortality in Type 2 Diabetes Mellitus. | Q48263499 | ||
| Effects of metabolic syndrome on bone mineral density, histomorphometry and remodelling markers in male rats | Q50114455 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 6191468 | |
| P577 | publication date | 2020-08-10 | |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus | |
| P478 | volume | 2020 |
Search more.